Tesla (NASDAQ:TSLA) shares rose 2.5% today, but the stock remains down ~17% year-to-date, suggesting the post-election ...

Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...

Johnny Depp as Captain Jack Sparrow? Robert Downey Jr. in "Tropic Thunder"? You'd be shocked by the roles that have received ...

OpenAI was cofounded by Musk and Altman in 2018 as a non-profit, with Musk leaving before the company took off. Musk’s ...

Tesla (TSLA) is advancing 3% after investment bank Benchmark started coverage of the automaker with a Buy rating.

Oppenheimer analyst Owen Lau maintained a Buy rating on S&P Global (SPGI – Research Report) today and set a price target of $610.00. The ...

Analysts at Oppenheimer said in a research note on Tuesday that billionaire Elon Musk's recent bid for ChatGPT parent OpenAI ...

At its current premarket price, Tesla's stock is down 33% since hitting a record high on Dec. 18, 2024, weeks after the ...

Bleakley Financial Group LLC lowered its position in PulteGroup, Inc. (NYSE:PHM – Free Report) by 5.3% during the fourth ...

Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “market perform” rating restated by analysts at Oppenheimer in a research note issued to investors on Monday, MarketBeat.com reports ...

Zurn Elkay has filed a registration statement (including a base prospectus) on Form S-3 and a preliminary prospectus supplement with the Securities and Exchange Commission (the “SEC”) for the offering ...